BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2385 related articles for article (PubMed ID: 31648971)

  • 1. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Inflammatory Bowel Disease Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):17-30. PubMed ID: 31648971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Cirrhosis Collaborators
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Chronic Respiratory Disease Collaborators
    Lancet Respir Med; 2017 Sep; 5(9):691-706. PubMed ID: 28822787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Diseases and Injuries Collaborators
    Lancet; 2024 May; 403(10440):2133-2161. PubMed ID: 38642570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Disease and Injury Incidence and Prevalence Collaborators
    Lancet; 2018 Nov; 392(10159):1789-1858. PubMed ID: 30496104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Disease and Injury Incidence and Prevalence Collaborators
    Lancet; 2017 Sep; 390(10100):1211-1259. PubMed ID: 28919117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Diabetes Collaborators
    Lancet; 2023 Jul; 402(10397):203-234. PubMed ID: 37356446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Mental Disorders Collaborators
    Lancet Psychiatry; 2022 Feb; 9(2):137-150. PubMed ID: 35026139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Forecasting Collaborators
    Lancet; 2024 May; 403(10440):2204-2256. PubMed ID: 38762325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Causes of Death Collaborators
    Lancet; 2017 Sep; 390(10100):1151-1210. PubMed ID: 28919116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Benign Prostatic Hyperplasia Collaborators
    Lancet Healthy Longev; 2022 Nov; 3(11):e754-e776. PubMed ID: 36273485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Diseases and Injuries Collaborators
    Lancet; 2020 Oct; 396(10258):1204-1222. PubMed ID: 33069326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Multiple Sclerosis Collaborators
    Lancet Neurol; 2019 Mar; 18(3):269-285. PubMed ID: 30679040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Oesophageal Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 DALYs and HALE Collaborators
    Lancet; 2018 Nov; 392(10159):1859-1922. PubMed ID: 30415748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017.
    GBD 2017 Stomach Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):42-54. PubMed ID: 31648970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Alcohol and Drug Use Collaborators
    Lancet Psychiatry; 2018 Dec; 5(12):987-1012. PubMed ID: 30392731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Epilepsy Collaborators
    Lancet Neurol; 2019 Apr; 18(4):357-375. PubMed ID: 30773428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Mortality Collaborators
    Lancet; 2017 Sep; 390(10100):1084-1150. PubMed ID: 28919115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Neurological Disorders Collaborator Group
    Lancet Neurol; 2017 Nov; 16(11):877-897. PubMed ID: 28931491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 120.